Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-079183
Filing Date
2025-04-11
Accepted
2025-04-11 17:03:57
Documents
22
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A d929796dpre14a.htm   iXBRL PRE 14A 828256
6 GRAPHIC g929796g01a01.jpg GRAPHIC 75596
7 GRAPHIC g929796g01j01.jpg GRAPHIC 247899
8 GRAPHIC g929796g02j02.jpg GRAPHIC 252776
9 GRAPHIC g929796g42b42.jpg GRAPHIC 142042
10 GRAPHIC g929796g43a43.jpg GRAPHIC 146401
  Complete submission text file 0001193125-25-079183.txt   3602713

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sldb-20241231.xsd EX-101.SCH 3750
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sldb-20241231_def.xml EX-101.DEF 3470
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20241231_lab.xml EX-101.LAB 3355
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20241231_pre.xml EX-101.PRE 2343
24 EXTRACTED XBRL INSTANCE DOCUMENT d929796dpre14a_htm.xml XML 147309
Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38360 | Film No.: 25833211
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)